Literature DB >> 16311606

Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2.

Xiaogang Li1, Ying Luo, Patrick G Starremans, Coleen A McNamara, York Pei, Jing Zhou.   

Abstract

Autosomal-dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and is characterized by progressive cyst formation and ultimate loss of renal function. Increased cell proliferation is a key feature of the disease. Here, we show that the ADPKD protein polycystin-2 (PC2) regulates the cell cycle through direct interaction with Id2, a member of the helix-loop-helix (HLH) protein family that is known to regulate cell proliferation and differentiation. Id2 expression suppresses the induction of a cyclin-dependent kinase inhibitor, p21, by either polycystin-1 (PC1) or PC2. The PC2-Id2 interaction is regulated by PC1-dependent phosphorylation of PC2. Enhanced Id2 nuclear localization is seen in human and mouse cystic kidneys. Inhibition of Id2 expression by RNA interference corrects the hyperproliferative phenotype of PC1 mutant cells. We propose that Id2 has a crucial role in cell-cycle regulation that is mediated by PC1 and PC2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311606     DOI: 10.1038/ncb1326

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  92 in total

1.  The retinitis pigmentosa protein RP2 interacts with polycystin 2 and regulates cilia-mediated vertebrate development.

Authors:  Toby Hurd; Weibin Zhou; Paul Jenkins; Chia-Jen Liu; Anand Swaroop; Hemant Khanna; Jeffrey Martens; Friedhelm Hildebrandt; Ben Margolis
Journal:  Hum Mol Genet       Date:  2010-08-20       Impact factor: 6.150

2.  Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.

Authors:  Xia Zhou; Lucy X Fan; Dorien J M Peters; Marie Trudel; James E Bradner; Xiaogang Li
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

3.  SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1.

Authors:  Xia Zhou; Lucy X Fan; Keguo Li; Ramani Ramchandran; James P Calvet; Xiaogang Li
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

Review 4.  Molecular diagnostics for autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 5.  Transient receptor potential channelopathies.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2010-02-04       Impact factor: 3.657

6.  Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.

Authors:  Binu Porath; Safia Livingston; Erica L Andres; Alexandra M Petrie; Joshua C Wright; Anna E Woo; Carol G Carlton; Richard Baybutt; Gregory B Vanden Heuvel
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-12

7.  Loss of polycystin-1 causes centrosome amplification and genomic instability.

Authors:  Lorenzo Battini; Salvador Macip; Elena Fedorova; Steven Dikman; Stefan Somlo; Cristina Montagna; G Luca Gusella
Journal:  Hum Mol Genet       Date:  2008-06-19       Impact factor: 6.150

8.  Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 protein.

Authors:  Xuefeng Su; Kaitlin Driscoll; Gang Yao; Anas Raed; Maoqing Wu; Philip L Beales; Jing Zhou
Journal:  Hum Mol Genet       Date:  2014-06-16       Impact factor: 6.150

9.  A mitotic transcriptional switch in polycystic kidney disease.

Authors:  Francisco Verdeguer; Stephanie Le Corre; Evelyne Fischer; Celine Callens; Serge Garbay; Antonia Doyen; Peter Igarashi; Fabiola Terzi; Marco Pontoglio
Journal:  Nat Med       Date:  2009-12-06       Impact factor: 53.440

Review 10.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.